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The effects of cytokines and heavy metals on the expression and localization of metallothioneins (MT@ within U373MG astrocytoma cells were 
analyzed by using indirect immunofluorescence using a monoclonal anti-MT antibody (MT45). IL-l, CdCl, (SO&M) or ZnCl, (SOO~M) remarkably 
augmented intracellular MT levels, whereas IL-6 or 10 PM of ZnCl, showed no inducing activity. From 24 to 48 h after the addition of CdCl, 
or IL-l. immunoreactive MTs were found in the cytoplasm and the nucleus. After 72 h, immunoreactive MTs accumulated in a granular form near 
the cell surfaces in the presence of CdCl, (SO PM) or IL-1 plus ZnCl, (10 PM). However, this accumulation was not observed when only fL-1 was 
added. Thus, Zn’+ facilitated the appearance of the granular form of immunoreactive MTs at a concentration where they do not induce MTs by 
themselves. 
Metallothioneln; In~erleukin-1; Interieukin-6; Heavy metal: Astrocytoma cell; U373MG cell 
1. INTRODUCTION 
Metallothioneins (MTs) are cysteine-rich, metal- 
binding proteins of low molecular weight. In mammals, 
they are inducible by a variety of factors including 
heavy metals, cytokines, glucocorticoids, phorbol es- 
ters, physical stress and infection, and are recently reck- 
oned as one of the acute-phase proteins ([I+ for re- 
view). 
The MT levels are dramatically elevated in the liver 
in response to lipopolysaccharide (LPS). The roles of 
monokines or interleukin-1 (IL-l) in the LPS-induced 
response has been well studied ([5] for review). IL-l is 
a strong stimulator of biosynthesis of MTs and other 
acute-phase proteins in hepatocytes [5-71. However, re- 
cent evidence implicates that interleukin-6 (IL-6) plays 
an major role in the MT-induction in the liver [8,9] as 
it does in the induction of other acute-phase proteins 
[lO,l I]. 
Several investigators have reported the expression or 
induction of MTs in the animal brain [I 2,131 and also 
abnormal accumulation of MTs in the brains of patients 
with Alzheimer’s disease [14]. The localization of MT 
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in astrocytes has been shown in the normal brain [13]. 
However, the available knowledge about the role and 
induction of brain MTs is still scarce. It is well known 
that, in the central nervous systems, cytokines including 
IL-l and IL-6 are produced by glial cells and act as 
regulators of nerve cell growth and differentiation [15]. 
The presence of IL-l and IL-6 within the brain implies 
that they might also act as MT-inducers in the brain. 
As previously reported, the stimulation by IL-l of a 
human astrocytoma cell line, U373MG, resulted in the 
induction of IL-6 IL-8 and monocyte chemotactic and 
activating factor (MCAF) [ 16,171. Therefore, we investi- 
gated the role of cytokines and heavy metals for the 
MT-induction in this astrocytoma cell line. 
2. MATERIALS AND METHODS 
2.1. Cytokines and ~n~ib~d~s 
Recombinant human IL-la (rhIL-la, 1-2x 107 Ulmg protein) was 
provided by Dainip~n Pha~a~uti~l Co. (Osaka). Recombinant 
human IL-6 (rhIL-6, 6 x lo6 Ulmg protein) was provided by Ajino- 
moto Co. (Yokohama). Preparation of the murine monoclonal anti- 
body specific for MTs, MT45 (K, y I), was reported previously [18], 
and the hybridoma culture supernatants were used for immunostain- 
ing. As a second antibody for indirect immunofluorescence, FITC- 
conjugated sheep anti-mouse Ig (Amersham, N.1031) was used. 
2.2, Cell culture 
Human astrocytoma U373MG cells were subcloned as described 
previously [l6] and cultured in monolayers in RPM1 1640 medium 
(GIBCO) supplemented with 10% heat-inactivated fetal calf serum 
(FCS), 2 mM glutamine. 1 mM sodium pyruvate and 50pM 2-mercap- 
toethanol. 
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Fig. I. Induction and localization of MTs in U373MG cells stimulated with heavy metals: A, untreated; B, cultured with 50 PM CdCl, for 48 h; 
C, cultured with 500 PM ZnCl, for 48 h; D, cultured with 50 PM CdCl, for 24 h; E, cultured with 50 PM CdCl, for 48 h; F, cultured with 50 PM 
CdCl, for 72 h. Pictures A-C and D-F were obtained from two independent experiments, respectively. 
2.3. Northern blot analysis 
A cDNA probe encoding the entire human MT 2a coding sequence 
was kindly provided by Dr. S. Yamazaki, Jichi Medical School, To- 
chigi. Other probes were prepared as described previously [li’]. North- 
ern blot analysis was carried out according to the method described 
previously ]16]. 
Indirect immunoffuorescence was carried out according to the 
method previously described 1181. U373MG cell monolayers (2 x lo4 
cells/well) grown on chamber-slides (Lab-Tek Tissue Culture Cham- 
ber/Slide, Nunc) were cultured with heavy metals and/or cytokines. 
The slides were centrifuged, and the cells were fixed with 3.5% formal- 
dehyde in phosphate-buffered saline (pH 7.2) (PBS) for 20 min and 
then treated with 0.2% Triton X-100 in PBS for 2 min at room temper- 
ature. The fixed cells were blocked with 1.0% bovine serum albumin 
(BSA)-PBS for 30 min and incubated with the MT45 antibody for 45 
min at room temperature. After extensive washing with PBS, the cells 
were treated with FITC-labeled second antibody in 1 .O% BSA-PBS for 
45 min at room temperature, washed with PBS, and mounted with 
Gel/Mount (Biom~a). The stained cells were observed and photo- 
graphed under a fluorescence microscope (Olympus, Tokyo). 
3. RESULTS 
Northern blot analysis revealed that U373MG cells 
also expressed MT mRNA in response to rhIL- 1 c1 (data 
not shown). The kinetics of mRNA induction for metal- 
lothionein (MT) was similar to that for IL-8 or MCAF 
(data not shown). Under the same conditions, U373MG 
cells express a high level of IL-6 mRNA and release IL-6 
activity into the supematants 1161. Thus, it was consid- 
ered to be necessary to determine whether or not the 
effect of IL-1 was indirectly mediated by the secreted 
IL-6. To determine the effects of IL-l and IL-6 on MT 
biosynthesis, we employed the indirect immunofluores- 
cence methods using a monoclonal anti-MT antibody 
(MT45) [18]. 
First, the induction of MTs by heavy metal ions was 
analyzed. A bright fluorescence was observed when 
U373MG cells were cultured with SO ,uM CdCl, (Fig. 
1B) or SO0 PM ZnCl, (Fig. 1C) for 48 h, whereas the 
intensity of fluorescence in untreated U373MG cells 
was very low (Fig. 1A). The increase in fluorescence 
intensity was much higher than that observed in HeLa 
S3 and FM3A cells under similar conditions [18]. 
The effect of Cd2+ on the expression and localization 
of MTs were examined after varying the duration of 
incubations (Fig. lD-F). A significant increase in fluo- 
rescence intensity was observed 12 h after the addition 
of the metal, and thereafter the fluorescence intensity 
gradually increased up to 24 h (data not shown). 
U373MG cells cultured for 24 h with SO PM CdCl, 
showed a bright fluorescence in the cytoplasm (Fig. 
1D). From 24 to 48 h after the addition of CdCl,, im- 
munoreactive MTs were found in both cytoplasm and 
nuclei (Fig. 1E). After 72 h, immunoreactive MTs accu- 
mulated in a granular form near the cell surfaces (Fig. 
1F). Almost the same responses were observed when 
ZnCl:, (SO0 PM) was added (data not shown). 
Next, U373MG cells were cultured with IL-l or IL-6 
to determine their MT-inducing activity. I~unoreac- 
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Fig. 2. Induction and localization f MTs in U373MG cells stimulated with IL-l (100 U/ml) and IL-6 (100 U/ml); A, untreated (48 h); B, cultured 
with rhIL-la for 48 h; C, cultured with rhIL-6 for 48 h; D, cultured with 5OpM CdCl,. for 48 h; E, cultured with rhIL-la for 24 h; F, cultured 
with rhIL-la for 48 h; G, cultured with rhIL-la for 72 h. Pictures A-D and E-G were obtained from two independent experiments, respectively. 
tive MTs were induced in U373MG cells when incu- 
bated with rhIL-lol at more than 10 U/ml for 48 h (Fig. 
2B), and the fluorescence intensity was comparable to 
that observed in the metal induction (Fig. 2B and D). 
In contrast, rhIL-6 did not augment the level of im- 
munoreactive MTs at con~ntrations as high as 100 
U/ml (Fig. 2C). 
Changes in the level and localization of IL- 1 -induced 
immunoreactive MTs were pursued after varying the 
duration of incubations (Fig. 2E-G). U373MG cells cul- 
tured with rhIL-la (100 U/ml) for 24 h showed a bright 
fluorescence in the cytoplasm (Fig. 2E). From 24 to 48 
h after the addition of rhIL-la, the MTs were found in 
both cytoplasm and nuclei (Fig. 2F). However, the flu- 
orescence intensity was reduced nearly to the basal level 
after 72 h, and the granular accumulations of im- 
munoreactivity shown in the metal induction was not 
detected in the IL-l induction (Fig. 2G). Moreover, 
additional IL-I at 48 h did not facilitate the appearance 
of the granules (data not shown). 
To determine the effect of extracellular Zn*+ on the 
IL-l-induced MT expression and localization, 
U373MG cells were incubated in the medium contain- 
ing rhIL-lol (100 U/ml) with or without 10 ,uM &Cl, 
(Fig. 3). After 48 h of culture, immunoreactive MTs 
were found in both cytoplasm and nuclei (Fig. 3B and 
C) irrespective of the addition of supplementary Zn2+. 
However, 72 h after the addition of rhIL-la plus ZnCl, 
(10 PM), immunorea~tive MTs accumulated in a granu- 
24 
lar form near the cell surfaces (Fig. 3G) while IL-l alone 
did not bring about any granular accumulation (Fig. 
3F). ZnCl, (10 PM) alone showed no effect (Fig. 3D and 
H). These data indicate that the granular accumulation 
of immunoreactive MTs near the cell surfaces is depend- 
ent on the extra~ellular Zn*+ concentration. 
4. DISCUSSION 
U373MG astrocytoma cells show strong proliferative 
responses to IL-l [16,19]. Upon IL-l stimulation, the 
cells also express several inflammatory cytokines [ 171. 
U373MG cells were not stimulated by other cytokines 
including IL-2, IL-4, IL-S, IL-6 and interferons 01 and 
y 1161. In the present study, Northern blot analysis and 
indirect i~unofluores~nce revealed that U373MG 
cells also expressed MTs in response to IL-la. Since 
U373MG cells release IL-6 into the supematants under 
the same conditions 1161, the MT-inducing activity of 
IL-6 was tested. However, IL-6 did not show any aug- 
mentation of intracellular MT levels (Fig. 2C). Al- 
though IL-6 is a major cytokine mediator of MT gene 
expression in hepatocytes [9], the present data indicate 
that IL-l, but not IL-6, is an MT-inducer in U373MG 
cells. It cannot be ruled out that IL-l induces MTs 
indirectly, e.g. via the production of IL-6 and IL-6 re- 
ceptors. U373MG cells possess a small number of IL-6 
receptors on their surfaces [ZO]. However, it seems un- 
likely that MT induction by IL-1 is mediated through 
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Fig. 3. Effect of ZnCl, (10 ,uM) on the expression a d localization f MTs induced by IL-1 (100 U/ml) in U373MG cells: A, untreated (48 h); B, 
cultured with rhIL-la for 48 h; C, cultured with rhIL-loz plus ZnC1, for 48 h; D, cultured with Z&l, for 48 h; E, untreated (72 h); F, cultured 
with rhIL-lar for 72 h; G, cultured with rhIL-la plus ZnCl, for 72 h; H, cultured with ZnCl, for 72 h. 
IL-6 receptors, since IL-6 itself does not activate this cell 
line in terms of cytokine production and proliferation 
[16] and anti-IL-6 antibody did not suppress the IL-l- 
induced cytokine production (our unpublished data). 
At present, it is not certain that astroglial cells in vivo 
produce MTs upon IL-1 stimulation. However, the fact 
that both IL-l receptors [21,22] and MTs (unpublished 
data) are localized in the brain hippocampal regions at 
higher levels implies the role of IL-l for MT induction 
in these regions. The MT-induction by IL-1 might be 
part of a protective response to minimize damage by 
free radicals generated during the IL-l-induced re- 
sponses [3]. 
Intraperitoneal administration of zinc or cadmium 
does not increase the brain MT levels [23,24] probably 
due to the blood-brain barrier [25]. However, MTs are 
induced by intracerebral zinc administration [26]. 
Therefore the primary function of MTs in the brain was 
suggested to be zinc homeostasis rather than metal de- 
toxification ([27] for review). In fact, the zinc content of 
the brain is greater than those of other tissues or organs. 
On this point, it is noteworthy that the Zr?’ concentra- 
tion required for MT induction is much higher than the 
Cd*+ concentration. 
Several investigators have reported the intranuclear 
localization of MTs, especially, in developing tissues 
and genital organs [28-301. We also observed a transient 
but marked localization of MTs in the nuclei of 
U373MG cells. The physiological role of the nuclear 
translocation of MTs and its mechanism are entirely 
obscure. One likely possibility is that MTs carry Zn*+ 
ions into the nucleus and supply the ions to nuclear 
zinc-requiring enzymes or factors under certain specific 
conditions. 
It is interesting that immunoreactive MTs accumulate 
after a prolonged incubation with heavy metal ions. 
This accumulation was not observed when only IL-1 
was added. The addition of a low concentration of Zn*+ 
with IL-l resulted in the appearance of the granular 
accumulations. Several investigators have reported on 
particulate forms of Zn- and Cu-MTs [31-331. At pres- 
ent, however, the physiological relevance and mecha- 
nism of the formation of particulate MT is not clear. 
The granular accumulation might be a step before the 
MTs are excreted. It is suggested that MT polypeptides 
are degraded mainly in lysosomes and excreted outside 
the cell. The apo-MTs have been shown to be even more 
sensitive to proteolysis than metal-including MTs ([34] 
for review). Therefore, without supplemental ZnCl,, the 
newly synthesized apo-MTs following stimulation by 
IL-l might be rapidly degraded. 
In conclusion, the induction of MTs by IL-l and 
heavy metals in the astrocytoma cell line, U373MG, is 
remarkable, and the basal MT expression is low. Thus, 
this in vitro induction system provides a useful model 
for elucidation of the mechanisms of the induction and 
intracellular metabolism of MTs. 
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